Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Acheson departs FDA

This article was originally published in The Tan Sheet

Executive Summary

David Acheson, the agency's first associate commissioner for foods leaves for a position in a new consultancy founded by former Health and Human Services Secretary Mike Leavitt. Acheson, appointed to associate commissioner in May 2007, said in an Aug. 7 e-mail that he will focus on food safety and the global food supply chain at Leavitt Partners in Washington. The role of the associate commissioner for foods is unclear following a recently announced FDA reorganization that will create a deputy commissioner for food (1"The Tan Sheet" July 13, 2009)

You may also be interested in...



FDA Creates Food Czar In Agency-Wide Reorganization

FDA will create a new position to oversee all food safety activities in response to recent food security problems and as part of a proposed agency-wide reorganization

Korean Bioclusters Offer Tax, Other Incentives To Attract Global Firms, Talent

South Korea has formulated new detailed policy measures to support the formation of major bioclusters, which will offer tax and other incentives in a bid to lure foreign firms and talent.

CDC Panel Backs Pfizer’s Maternal RSV Vaccine But Leaves Room For AstraZeneca/Sanofi’s Beyfortus

Abrysvo is recommended for use in pregnant people 32-36 weeks gestation if administered from September to January. For infants whose mothers were not vaccinated in this window, nirsevimab is recommended for prevention of respiratory syncytial virus infection.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103196

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel